Cadonilimab With Chemotherapy in Treating Advanced Biliary Cancer

Clinical trial NCT05978609 · UNKNOWN

Trial details

NCT number: NCT05978609
Sponsor: West China Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Cholangiocarcinoma Non-resectable

Start date: 2023-07-01
Primary completion: 2025-07-01
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.